HSP90 inhibitors: current development and potential in cancer therapy.
Sidera K, Patsavoudi E.
Recent Pat Anticancer Drug Discov · review; journal article · DOI 10.2174/157488980901140428100532 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för Hsp90 inhibitor. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
7 hitsHsp90 inhibitors as anti-cancer agents, from basic discoveries to clinical development.
Soga S, Akinaga S, Shiotsu Y.
Curr Pharm Des · review; journal article · DOI 10.2174/138161213804143617Hsp90 inhibitors.
Pillai RN, Ramalingam SS.
J Thorac Oncol · review; journal article · DOI 10.1097/jto.0b013e31826df2bbHSP90 inhibitors for cancer therapy and overcoming drug resistance.
Jhaveri K, Modi S.
Adv Pharmacol · research support, non-u.s. gov't; review; journal article · DOI 10.1016/b978-0-12-397927-8.00015-4HSP90 inhibitors as therapy for multiple myeloma.
Usmani SZ, Chiosis G.
Clin Lymphoma Myeloma Leuk · review; journal article · DOI 10.1016/j.clml.2011.03.027Hsp90 inhibitors as promising agents for radiotherapy.
Kabakov AE, Kudryavtsev VA, Gabai VL.
J Mol Med (Berl) · review; journal article · DOI 10.1007/s00109-009-0562-0Purine-scaffold Hsp90 inhibitors.
Taldone T, Chiosis G.
Curr Top Med Chem · research support, non-u.s. gov't; research-article; review; journal article; research support, n.i.h., extramural · DOI 10.2174/156802609789895737